奈克塔制药 NKTR
$37.26 +$1.11 (+3.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $37.26 0.00%
开盘$36.58
昨收$36.15
当日区间$36.44 – $37.58
成交量686.4K
市值$1.27B
市盈率（TTM）–
股息率–
NKTR 相关新闻
匹配 Nektar Therapeutics 或代码 NKTR 的头条新闻，按最新排序。
- BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $178
- CCORF Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $153
- Nektar Therapeutics | SCHEDULE 13G/A: Others
- Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GREER R SCOTT
- Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WHITFIELD ROY A
- Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $192
- A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $80 to $192
- CCORF Initiates Nektar Therapeutics(NKTR.US) With Buy Rating, Announces Target Price $153
- Piper Sandler Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $192 正面
- TD Cowen Maintains Nektar Therapeutics(NKTR.US) With Buy Rating
- Oppenheimer Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $140 正面
- Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $123
- H.C. Wainwright Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Cuts Target Price to $135 负面
- Citi Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Raises Target Price to $151 正面
- A Quick Look at Today's Ratings for Nektar Therapeutics(NKTR.US), With a Forecast Between $134 to $185
暂无评论——快来第一个聊聊 NKTR。
登录后参与讨论。